1. Wang, Hui-Hui, Wen, Fei-Qiu, Dai, Dong-Ling, Liu, Si-Xi, Yang, Qing-Hua. . Infant cholestasis patient with a novel missense mutation in the AKR1D1 gene successfully treated by early adequate supplementation with chenodeoxycholic acid: A case report and review of the literature. In World journal of gastroenterology, 24, 4086-4092. doi:10.3748/wjg.v24.i35.4086. https://pubmed.ncbi.nlm.nih.gov/30254413/
2. Gathercole, Laura L, Nikolaou, Nikolaos, Harris, Shelley E, Cox, Roger D, Tomlinson, Jeremy W. 2022. AKR1D1 knockout mice develop a sex-dependent metabolic phenotype. In The Journal of endocrinology, 253, 97-113. doi:10.1530/JOE-21-0280. https://pubmed.ncbi.nlm.nih.gov/35318963/
3. Nikolaou, Nikolaos, Gathercole, Laura L, Kirkwood, Lucy, Hodson, Leanne, Tomlinson, Jeremy W. 2019. AKR1D1 regulates glucocorticoid availability and glucocorticoid receptor activation in human hepatoma cells. In The Journal of steroid biochemistry and molecular biology, 189, 218-227. doi:10.1016/j.jsbmb.2019.02.002. https://pubmed.ncbi.nlm.nih.gov/30769091/
4. Nikolaou, Nikolaos, Gathercole, Laura L, Marchand, Lea, Hodson, Leanne, Tomlinson, Jeremy W. 2019. AKR1D1 is a novel regulator of metabolic phenotype in human hepatocytes and is dysregulated in non-alcoholic fatty liver disease. In Metabolism: clinical and experimental, 99, 67-80. doi:10.1016/j.metabol.2019.153947. https://pubmed.ncbi.nlm.nih.gov/31330134/